CHOP Researchers Repurpose Cancer Immunotherapy Tools for COVID-19 Vaccine Research

Cancer researchers at Children’s Hospital of Philadelphia (CHOP) are repurposing tools used for the development of cancer immunotherapies to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the virus, according to a CHOP press release.